Lountzis Asset Management ERFSF trades
Paul Lountzis
Paul Lountzis Eurofins Scientific SE stake
total: 144
Trades details
- Total transactions:
- 3
- New positions:
- 1
- Added:
- 2
- Held since:
- 2023 Q1
- Held for:
- 15 quarters
- Latest activity:
- 2026 Q3
According to 2026 Q3 report, Paul Lountzis holds 16,195 Eurofins Scientific SE (ERFSF) shares with a market value of roughly $1.38M accounting for 0.46% of the overall portfolio. To date, the estimated cost basis is nearly $76.48 for "buy" trades. Lountzis Asset Management first purchased ERFSF in 2023 Q1, initially acquiring 6,518 shares. Since the initial investment in Eurofins Scientific SE (ERFSF), Lountzis Asset Management has made 2 more transactions.
When did Paul Lountzis buy Eurofins Scientific SE (ERFSF)?
Paul Lountzis first invested in Eurofins Scientific SE (ERFSF) in 2023 Q1 at the reported quarter-end price of $66.89 per share.
What's the cost basis of Lountzis Asset Management's ERFSF stake?
The estimated cost basis for Eurofins Scientific SE (ERFSF) stake is around $76.48 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $76.48
Paul Lountzis's historical trades in Eurofins Scientific SE
3 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q3
|
0.46%
|
16,195
|
$84.99
|
$1,376,346
|
+117.88% (+8,762)
|
+0.25%
|
|
2024 Q3
|
0.20%
|
7,433
|
$63.36
|
$470,924
|
+14.04% (+915)
|
+0.02%
|
|
2023 Q1
|
0.26%
|
6,518
|
$66.89
|
$436,000
|
new
|
+0.26%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.